Tritonix.ai

News / Taiwan / economic_daily

Bora Pharmaceuticals Posts Second-Highest Monthly Revenue in August

Health Technology · Pharmaceuticals: Major · economic_daily · 2026-09-07

Bora Pharmaceuticals achieved its second-highest monthly revenue of NT$2.18 billion in August, driven by strong CDMO shipments and robust sales of specialty drugs in the US.

What Happened

Strong Revenue Growth: Bora Pharmaceuticals reported August revenue of NT$2.18 billion, a 59.22% year-on-year increase, marking its second-highest monthly performance as deferred CDMO orders were fulfilled.

Specialty Drug Success: Sales of the flagship specialty drug Vigabatrin, under the US subsidiary Upsher-Smith, reached record highs, contributing to improved profit margins within the global sales division.

Asset Optimization: The company announced a sale-leaseback agreement for its Zhongli Plant No. 2, expected to generate a disposal gain of NT$114 million and improve overall capital efficiency and asset structure.

Future Outlook: With the integration of the Weider brand and upcoming retail peak seasons in the US, Bora remains optimistic about its growth trajectory, focusing on CDMO technological advancements and market expansion.

Read original

More in Health Technology

Bora Pharmaceuticals Reports 59% Revenue Surge in August, Announces Asset Divestiture

Health Technology · economic_daily · 2026-09-07

Bora Pharmaceuticals posted a 59.2% year-over-year revenue increase for August and unveiled an $850 million asset sale-leaseback deal for its Zhongli plant.

6472

Bora Pharmaceuticals Reports Strong August Revenue Growth of 59.22% YoY

Health Technology · cnyes · 2026-09-07

Bora Pharmaceuticals (6472.TW) announced August revenue of NT$2.185 billion, marking a significant 59.22% year-over-year increase and 14.89% monthly growth.

6472

Bora Pharmaceuticals Reports Strong August Revenue and Asset Divestiture

Health Technology · cnyes · 2026-09-07

Bora Pharmaceuticals achieved its second-highest monthly revenue of NT$2.185 billion in August, bolstered by CDMO shipments and a strategic asset sale-leaseback.

1271, 6472

Latest in Taiwan

Taiwan Stocks Surge as Foreign Investors Pour $2.7 Billion into Market, Hitting Second-Highest Close

Electronic Technology · economic_daily · 2026-09-07

Led by TSMC and MediaTek, the Taiwan Weighted Index jumped 775 points to its second-highest close ever, fueled by massive foreign buying.

2330, 5274

UBS Downgrades Largan Precision to 'Sell' on Valuation Concerns

Electronic Technology · economic_daily · 2026-09-07

UBS has downgraded Largan Precision from 'Buy' to 'Sell', citing excessive market optimism regarding its CPO business and high valuation multiples.

3008

Fubon and KGI Securities Ramp Up Fundraising Amid Bullish Taiwan Stock Market

Finance · economic_daily · 2026-09-07

Taiwanese brokerages Fubon Securities and KGI Securities are aggressively raising capital through bond issuances and syndicated loans to support business growth.

2881

Taiwan Stock Market Sees Record-High Monthly Regular Savings Investment in August

Finance · economic_daily · 2026-09-07

Taiwan's regular savings investment in stocks reached NT$36.87 billion in August, marking the second-highest monthly total as retail investors remain committed.